New Alzheimer's drug shows promise in early trial
Symptom relief
Completed
This early-phase study tested whether phenserine, a new drug, could help people with early or mild Alzheimer's disease. Sixteen participants took either phenserine or the standard drug donepezil for 8 weeks. Researchers measured blood markers of cell death, brain cell health, and…
Phase: PHASE1 • Sponsor: Helse Stavanger HF • Aim: Symptom relief
Last updated Jun 15, 2026 19:03 UTC